CYNTHIA GARDNER: Open Payments
NPI 1851584742 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 30 payments from 7 companies in 2025. Trend: 2023 $311 · 2024 $423 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $368 |
| Lilly USA, LLC | 8 | $174 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Amgen Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: Wegovy, MOUNJARO, Rybelsus, Ozempic, BREZTRI, OTEZLA, TRELEGY ELLIPTA, Qelbree.
Industry payments across TX — which companies pay providers there.
